跳至主要内容
临床试验/JPRN-UMIN000021414
JPRN-UMIN000021414已完成未知

Study on the effect of combination therapy of alpha-1 blocker and transdermal oxybutynin hydrochloride in patients with overactive bladder due to benign prostatic hyperplasia - Study on the combination therapy of alpha-1 blocker and transdermal oxybutynin in patients with overactive bladder due to benign prostatic hyperplasia

Department of Renal and Urologic Surgery, Asahikawa Medical University0 个研究点目标入组 80 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Qmax on uroflowmetry 5ml/sec or less, postvoid residual urine 100ml or more, patients who underwent radiation to the prostate

研究者

发起方
Department of Renal and Urologic Surgery, Asahikawa Medical University

相似试验